FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

734452007: Saxagliptin hydrochloride (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3506885018 Saxagliptin hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3506886017 Saxagliptin hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
17351000188114 saxagliptin chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
839491000172112 chlorhydrate de saxagliptine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Saxagliptin hydrochloride (substance) Is a Saxagliptin (substance) false Inferred relationship Some
Saxagliptin hydrochloride (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Dipeptidyl peptidase IV inhibitor (disposition) true Inferred relationship Some
Saxagliptin hydrochloride (substance) Is a Substance with alcohol structure (substance) true Inferred relationship Some
Saxagliptin hydrochloride (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Saxagliptin (substance) true Inferred relationship Some
Saxagliptin hydrochloride (substance) Is a Dipeptidyl peptidase IV inhibitor true Inferred relationship Some
Saxagliptin hydrochloride (substance) Is a Nitrile true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Saxagliptin (as saxagliptin hydrochloride) 2.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Saxagliptin hydrochloride (substance) Inferred relationship Some 1
Product containing precisely saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Saxagliptin hydrochloride (substance) Inferred relationship Some 1
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Saxagliptin hydrochloride (substance) Inferred relationship Some 2
Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Saxagliptin hydrochloride (substance) Inferred relationship Some 2
Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Saxagliptin hydrochloride (substance) Inferred relationship Some 2
Product containing precisely metformin hydrochloride 850 milligram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Saxagliptin hydrochloride (substance) Inferred relationship Some 2
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Saxagliptin hydrochloride (substance) Inferred relationship Some 2
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 10 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Saxagliptin hydrochloride (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start